Fresenius Group Overview
- The Health Care Group
-
Stories
-
![]()
More ‘Quality of Life’ in clinics
-
![]()
Ready to help the littlest ones
-
![]()
Fresenius Medical Care celebrates first 20 years
-
![]()
Making mistakes to avoid them
-
![]()
A vast island nation
-
![]()
"I want to help others, so they won’t give up"
-
![]()
17,962 miles halfway around the world
-
![]()
A polyclinic in Ghana
-
![]()
Dialysis patient succeeds in giving birth
-
![]()
Returning a hospital to health in Germany
-
![]()
The future is purple
-
![]()
From a local pharmacy to a global corporation
-
- Investors
-
Media
![]()
Contact
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com - Careers
More ‘Quality of Life’ in clinics
Ready to help the littlest ones
Fresenius Medical Care celebrates first 20 years
Making mistakes to avoid them
A vast island nation
"I want to help others, so they won’t give up"
17,962 miles halfway around the world 
A polyclinic in Ghana
Dialysis patient succeeds in giving birth
Returning a hospital to health in Germany
The future is purple
From a local pharmacy to a global corporationMedia
Corporate Communications
Here you can find a variety of information:
- Press releases and Brief news
- Key dates for journalists
- Pictures, videos, audio files, press kits and other documents
- Social media channels
- Personal contacts
Our Corporate Communications team can be reached at pr-fre@fresenius.com.
“A pharmacy today? We need to expand it or add something new to it.” (Dr. Eduard Fresenius, Founder, 1912)
-
![]()
Import (ICS)August 01, 2017 | Bad Homburg, Germany
Conference Call Q2 2017, Fresenius
Live webcast
News
- Brief News
Fresenius wins award for Quirónsalud acquisition
Fresenius was presented yesterday with the Corporate Finance Award for the company's acquisition of Quirónsalud, Spain’s largest private hospital operator. The award is given annually by the major German business daily Börsen-Zeitung for transactions judged to be outstanding in both strategical and financial terms. Fresenius won in the Large Caps category, which groups major companies. With the Quirónsalud acquisition, the Börsen-Zeitung said, “Fresenius succeeded in making a quantum leap in the hospital business."
June 23, 2017Fresenius
![]()
-
![]()
Brief NewsFresenius Helios opens new hospital facility in northern Germany
HELIOS Hospital Wesermarsch has gone into operation in a newly built facility in the northern German town of Nordenham. The new hospital building has 120 patient beds, three operating rooms and a hybrid cardiac catheterization lab. Capacity can be increased to 235 beds, if needed. Fresenius Helios invested €36 million in the facility, which took about three years to build, with the County of Wesermarsch contributing an additional €10 million.
May 22, 2017Fresenius Helios
-
![]()
![]()
-
![]()
![]()
-
![]()
Brief NewsFresenius' Investment Grade Rating remains unaffected
Following Fresenius’ announcement to acquire Akorn, Inc. and Merck KGaA’s biosimilars business, the rating agencies Standard & Poor’s (BBB-, stable), Moody’s (Baa3, stable) and Fitch (BBB-, stable) confirm the corporate credit ratings of Fresenius to be unaffected.
April 26, 2017Fresenius
-
![]()
Brief NewsFresenius Kabi USA wins supplier award from Vizient
Fresenius Kabi USA has won the prestigious 2016 Pharmaceutical Supplier of the Year Award from Vizient Inc., the largest group purchasing organization for U.S. academic medical centers, community hospitals, pediatric facilities, integrated health delivery networks and non-acute health care providers. Fresenius Kabi has won six Vizient awards for service excellence in recent years.
April 24, 2017Fresenius Kabi
- Brief News
Fresenius Vamed wins contract for university hospital building in Austria
Fresenius Vamed will realize a 350-bed building at University Hospital St. Pölten, in Austria. Working with a partner company, Fresenius Vamed will be the general contractor on the €176 million project. The new building will have some 21,000 square meters (226,000 square feet) of floor space, housing a range of specialist wards. Construction is scheduled to begin in 2019.
April 21, 2017Fresenius Vamed
Brief NewsFresenius Helios modernizing hospital in central Germany
Fresenius Helios is investing €14 million to modernize its hospital in Wipperfürth, North Rhine-Westphalia. Starting late this month, two wards will be completely renovated and expanded, with three delivery rooms to follow. To minimize disruptions to hospital operations, the individual renovations are being carried out in sequence. When completed in early 2019, they will provide more comfort for patients and reduce the distances that need to be walked inside the hospital.
April 06, 2017Fresenius Helios
- Brief News
Fitch rates Fresenius Finance Ireland Bonds at BBB- and affirms Fresenius at BBB-
Fitch Ratings has assigned Fresenius Finance Ireland’s €2,600 million notes issued to finance the acquisition of Quirónsalud an instrument rating of BBB-. It also affirmed Fresenius’ corporate credit rating at BBB-. The outlook is stable. The €2,600 million notes were drawn under the newly established Fresenius European Medium Term Note (EMTN) Program and issued by Fresenius Finance Ireland plc., a wholly owned subsidiary of Fresenius SE & Co. KGaA.
March 23, 2017Fresenius
Brief NewsFresenius Helios opens new hospital building in Duisburg
Fresenius Helios has opened the new building at its hospital in the western German city of Duisburg. The 22,000-square-meter (237,000-square-foot) structure will accommodate up to 350 inpatients. Construction took two years, with Fresenius Helios investing €50 million in the new building. The move from the existing facility into the new building will start later this month.
March 20, 2017Fresenius Helios
- Brief News
Quirónsalud to build Spain’s first proton beam therapy center
Quirónsalud, a unit of Fresenius Helios, is investing about €40 million to build a proton beam therapy center in Madrid. Scheduled for opening in 2019, it will be the first facility of this type for treating cancer patients in Spain. Currently, every patient who can benefit from proton beam therapy must seek treatment outside the country. In proton beam therapy, the use of a high-energy beam allows tumors to be irradiated with lower total doses of radiation and reduced exposure to surrounding tissue compared with conventional radiation therapy. Quirónsalud will also modernize and expand its radiotherapy clinics in Palmaplanas (Mallorca) and Seville.
March 10, 2017Fresenius Helios
![]()
-
![]()
![]()
-
![]()
Initial conversion price of equity-neutral convertible bonds fixed
February 02, 2017Fresenius
-
![]()
Fresenius Medical Care reaches agreement on outstanding payments
January 31, 2017Fresenius Medical Care
-
U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation
January 26, 2017Fresenius Medical Care
Fresenius successfully places equity-neutral convertible bonds
January 19, 2017Fresenius
-
Fresenius announces issuance of equity-neutral convertible bonds
January 19, 2017Fresenius
![]()
-
![]()
Statement of Fresenius Medical Care Regarding Lawsuit Challenging Premium Assistance Regulation: U.S. Court Ruling Granting Temporary Restraining Order
January 13, 2017Fresenius Medical Care
Contact
Do you have other questions or need any more information?
Your contact:
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
Contact
